CMS Repeals Final Rule on Digital Therapeutics in A Year of Shifting Guidance
The absence of an established, repeatable, and scalable path to commercialization and prescription of DTx has bottlenecked broader uptake, says one physician leader. Key Takeaways The Centers for Medicare & Medicaid Services has repealed its...
More Info